CVS Health Co. (NYSE:CVS) Shares Sold by Register Financial Advisors LLC

Register Financial Advisors LLC lowered its stake in CVS Health Co. (NYSE:CVS) by 2.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 19,905 shares of the pharmacy operator’s stock after selling 586 shares during the quarter. Register Financial Advisors LLC’s holdings in CVS Health were worth $1,588,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CVS. Atticus Wealth Management LLC increased its position in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. USA Financial Formulas increased its holdings in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in shares of CVS Health in the 4th quarter valued at approximately $32,000. Creekmur Asset Management LLC purchased a new position in shares of CVS Health during the 4th quarter valued at approximately $34,000. Finally, Steph & Co. grew its position in shares of CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

NYSE:CVS traded up $0.73 during midday trading on Friday, hitting $59.09. 14,343,233 shares of the stock were exchanged, compared to its average volume of 12,103,906. The business has a 50-day moving average price of $59.56 and a two-hundred day moving average price of $70.19. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $74.18 billion, a price-to-earnings ratio of 10.38, a P/E/G ratio of 0.58 and a beta of 0.53. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the business earned $2.20 EPS. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Sell-side analysts predict that CVS Health Co. will post 7.02 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CVS. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Robert W. Baird began coverage on CVS Health in a report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price objective for the company. Bank of America decreased their target price on CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Finally, SVB Leerink reissued a “market perform” rating and set a $60.00 price target (down from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Eleven equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $75.05.

Insider Transactions at CVS Health

In related news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.24% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.